𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preclinical Pharmacology of ABT-594: A Nicotinic Acetylcholine Receptor Agonist for the Treatment of Pain

✍ Scribed by Michael D. Meyer; David J. Anderson; Jeffrey E. Campbell; Sherry Carroll; Kennan C. Marsh; A. David Rodrigues; Michael W. Decker


Book ID
109105517
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
116 KB
Volume
6
Category
Article
ISSN
1080-563X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Neuronal nicotinic acetylcholine recepto
✍ Michael D. Meyer πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 1 views

## Abstract Neuronal nicotinic acetylcholine receptor (nAChR) agonists have been demonstrated to exhibit antinociceptive, antihyperalgesic, and antiallodynic effects across a range of preclinical models of pain. Yet, to date, no drugs have been successfully developed and approved for the treatment